U.S. Plans to Ship Abbott $5 Rapid Tests to States to Distribute
(Bloomberg) -- After purchasing 150 million new rapid Covid tests from Abbott Laboratories, the U.S. government plans to distribute “the overwhelming majority” to states, a top Trump administration official overseeing testing said.
Governors will be able to use the tests to help reopen schools and protect first responders, Brett Giroir told reporters. Distribution is to begin in mid-September, with states coping with natural disasters, such as Louisiana in the midst of hurricane season, first in line, he said.
Most will be shipped to governors, who can allot them “according to their distribution plans,” Giroir said. “We fully, fully want to support them in that.”
Abbott's rapid tests will also be sent to assisted-living facilities, senior centers, home health staff and nursing homes for at-risk elderly individuals. They'll be used to increase screenings for populations of color by way of historically Black colleges and universities and Native American tribes, Giroir said.
Giroir touched on a controversial recent change to Centers for Disease Control and Prevention guidance that said asymptomatic people don't “necessarily need” to be tested for the virus, even if they've been exposed to someone with coronavirus or attended a gathering “without widespread mask wearing or physical distancing.”
Asymptomatic Testing
“Not only do we fully support and have provided guidance to test asymptomatic individuals, but we just bought 150 million tests” to support that, Giroir said.
The U.S. reported more than 6 million Covid-19 cases this week and 184,000 deaths. Hotspots continue to rage in 29 states, according to a Kaiser Family Foundation analysis, even as testing -- key to identifying cases and mitigating the new coronavirus's spread -- has steadily declined since late July, to about 4.7 million tests a week in late August.
As Americans go back to work and school, rapid testing technology is expected to play a key role in staving off further spread, but it's been in short supply except at nursing homes, where the federal government sent two earlier rapid tests.
Several states formed an alliance last month aimed at purchasing more than 3 million of the rapid antigen tests, in an effort they described as circumventing the federal government. An antigen is a viral protein, or a piece of one, that indicates the pathogen's presence.
Read More:
- States Show Fury at Trump With Bipartisan Testing Plan
- U.S. Buys Almost All Abbott's $5 Rapid Tests Made This Year
- Months Into Pandemic, U.S. Still Can't Get Speedy Testing Right
The new Trump administration plan appears to be aimed at alleviating that rapid-testing crunch, while remaining in line with a longtime strategy of having localities lead on testing.
Abbott's rapid BinaxNOW test, which was authorized by the Food and Drug Administration last week, is designed to give results within 15 minutes and doesn't require laboratory equipment -- a major selling point after test-material shortages delayed results for other types of Covid-19 tests.
Giroir declined to provide further details of the plan, saying only that the tests would likely be sent directly to recipients and that distribution is being done in collaboration with the Department of Defense's Defense Logistics Agency.
Ideally, “I would probably spend two months putting a bow around every plan before we announced it in the media,” he said. “But people's lives are at stake. Their children need to go back to school.”
©2020 Bloomberg L.P.
-
We May Need Another Tukaram Mundhe To Fight Air Pollution | The Reason Why
Developers may install basic measures such as sprinklers and green nets, resume work, and continue violating rules when this equipment stops working.
-
Extracting Value From Battery Scrap Could Be Challenging For India | The Reason Why
A discarded lithium-ion battery still contains valuable materials such as lithium, nickel and cobalt. These can be recovered and reused. When such batteries are crushed and shredded, they produce a dark powder called black mass.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.